4.8 Article

Mouse and human neutrophils induce anaphylaxis

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 4, Pages 1484-1496

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI45232

Keywords

-

Funding

  1. Institut Pasteur, the Institut National de la Sante et de la Recherche Medicate (INSERM)
  2. Agence Nationale de la Recherche (ANR) [05-JCJC-0236-01, GENOPAT-09-GENO-014-01]
  3. Fondation pour la Recherche Medicate (FRM)
  4. European Union [MUGEN LSHG-CT-2005-005203]
  5. Societe Francaise d'Allergologie (SPA) (Soutien de la recherche en allergologie)
  6. Balsan company
  7. Institut Pasteur (Bourse Roux)
  8. Ministry of Education, Science, Culture, Sports and Technology of Japan

Ask authors/readers for more resources

Anaphylaxis is a life-threatening hyperacute immediate hypersensitivity reaction. Classically, it depends on IgE, Fc epsilon RI, mast cells, and histamine. However, anaphylaxis can also be induced by IgG antibodies, and an IgG1-induced passive type of systemic anaphylaxis has been reported to depend on basophils. In addition, it was found that neither mast cells nor basophils were required in mouse models of active systemic anaphylaxis. Therefore, we investigated what antibodies, receptors, and cells are involved in active systemic anaphylaxis in mice. We found that IgG antibodies, Fc gamma RIIIA and Fc gamma RIV, platelet-activating factor, neutrophils, and, to a lesser extent, basophils were involved. Neutrophil activation could be monitored in vivo during anaphylaxis. Neutrophil depletion inhibited active, and also passive, systemic anaphylaxis. Importantly, mouse and human neutrophils each restored anaphylaxis in anaphylaxis-resistant mice, demonstrating that neutrophils are sufficient to induce anaphylaxis in mice and suggesting that neutrophils can contribute to anaphylaxis in humans. Our results therefore reveal an unexpected role for IgG, IgG receptors, and neutrophils in anaphylaxis in mice. These molecules and cells could be potential new targets for the development of anaphylaxis therapeutics if the same mechanism is responsible for anaphylaxis in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available